We targeted expression of human/¯y chimeric Bcr-Abl proteins to the developing central nervous system (CNS) and eye imaginal disc of Drosophila melanogaster. Neural expression of human/¯y chimeric P210 Bcr-Abl or P185 Bcr-Abl rescued abl mutant¯ies from pupal lethality, indicating that P210 and P185 Bcr-Abl can substitute functionally for Drosophila Abl during axonogenesis. However, increased levels of neurally expressed P210 or P185 Bcr-Abl but not Drosophila Abl produced CNS defects and lethality. Expression of P210 or P185 in the eye imaginal disc produced a dominant rough eye phenotype that was dependent on dosage of the transgene. Drosophila Enabled, previously identi®ed as a suppressor of the abl mutant phenotype and substrate for Drosophila Abl kinase, had markedly increased phosphotyrosine levels in Bcr-Abl expressing Drosophila, indicating that it is a substrate for Bcr-Abl as well. Drosophila, therefore, is a suitable model system to identify Bcr-Abl interactions important for signal transduction and oncogenesis.
Introduction
The c-abl proto-oncogene encodes an ubiquitously expressed non-receptor protein tyrosine kinase localized in the cytoplasm and nucleus (reviewed by Laneuville, 1995; Pendergast, 1996) . The normal function of c-Abl in mammals is not fully known, but a number of observations suggest a role for c-Abl in cell proliferation and dierentiation. Studies of mice carrying targeted disruptions in the c-abl gene that result in a protein null or a carboxy-terminal truncated protein implicate a role for Abl in T and B cell dierentiation and maturation (Schwartzberg et al., 1991; Tybulewicz et al., 1991) . In the nucleus, c-Abl binding to DNA and c-Abl kinase activity are regulated during cell cycle progression (Kipreos and Wang, 1992; Welch and Wang, 1993) . Nuclear c-Abl has been implicated in the regulation of gene transcription (Baskaran et al., 1993) and cell growth (Sawyers et al., 1994; Welch and Wang, 1995; Wong et al., 1995) . Nuclear c-Abl kinase is activated by ionizing radiation and other DNA-damaging agents and is proposed to play a role in the growth arrest response to DNA-damage (Kharbanda et al., 1995; Yuan et al., 1996; Baskaran et al., 1997; Shafman et al., 1997) .
Much less is known about the function of cytoplasmic c-Abl which co-localizes with F-actin stress ®bers in ®broblasts (Van Etten et al., 1994) . The observation that integrin mediated cell adhesion alters the subcellular localization of c-Abl between nuclear and cytoplasmic compartments and regulates c-Abl tyrosine kinase suggests a role for c-Abl in transmitting integrin signals to the nucleus (Lewis et al., 1996) .
The c-abl proto-oncogene is also found in Drosophila where genetic analyses have implicated Abl in the regulation of cell-cell interactions and revealed a role for Abl kinase function in axonogenesis (Gertler et al., 1989; Bennett and Homann, 1992) . Unlike vertebrate c-Abl, Drosophila Abl is primarily cytoplasmic (Gertler et al., 1989) . The Drosophila abl gene is expressed at high levels in dierentiating neurons and muscles during embryogenesis and pupation (Bennett and Homann, 1992) . Abl mutant¯ies either fail to emerge (eclose) from their pupal cases or are present as adults having rough eyes, a reduced lifespan and reduced fecundity (Henkemeyer et al., 1987) . Mutagenesis screens to isolate second site mutations that interact genetically with abl identi®ed mutations in three genes, disabled (dab) (Gertler et al., 1989) , prospero (pros) (Gertler et al., 1993) , and failed axon connections (fax) (Hill et al., 1995) , that enhanced the abl mutant phenotype, and in one gene, enabled (ena), , that suppressed the abl mutant phenotype.
In chronic myelogenous leukemia (CML) and in Philadelphia chromosome positive (Ph + ) acute lymphocytic leukemia (ALL), a reciprocal translocation of the proto-oncogene c-abl from chromosome 9 to the breakpoint cluster region (bcr) of chromosome 22 results in activation of the c-abl oncogene. The resulting hybrid bcr-abl fusion gene encodes a 210 kD Bcr-Abl fusion protein (P210) in the case of CML, or a smaller 185 kD Bcr-Abl fusion protein (P185) in the case of Ph + ALL, with deregulated, elevated tyrosine kinase activity (reviewed by Kantarjian et al., 1993) .
The role of Bcr-Abl tyrosine kinase in transformation is not known. The fact that transgenic mice expressing P210 or P185 Bcr-Abl develop leukemias indicates that Bcr-Abl expression is both necessary and sucient for development of leukemias (Heisterkamp et al., 1990; Honda et al., 1995) . Two notable features of CML and Ph + ALL are the abnormal proliferation of progenitor stem cell clones and the premature release of primitive and committed malignant Ph + -positive myeloid progenitors from the bone marrow microenvironment and their subsequent appearance in the peripheral blood (reviewed by Verfaillie et al., 1997) . Additional evidence that Bcr-Abl can alter cytoskeletal function comes from studies of Bcr-Abl transformed cell lines which exhibit altered cell motility and other defects of cytoskeletal function (Salgia et al., 1997) . These observations implicate Bcr-Abl in cell proliferation, dierentiation, and adhesion pathways and indicate the existence of downstream targets of Bcr-Abl kinase.
A number of proteins that physically complex with Bcr-Abl and/or show elevated levels of phosphotyrosine in the presence of Bcr-Abl have been identi®ed and include proteins associated with focal adhesions (Salgia et al., 1995a (Salgia et al., , b, 1996 , as well as components of the Ras and phosphoinositide-3-kinase signal transduction pathways and other cytoplasmic and nuclear proteins (reviewed by Laueuville, 1995) . However, such studies do not necessarily identify relevant interactions that play an essential role in Bcr-Abl signal transduction and oncogenesis. Since Drosophila homologs exist for many of the proteins reported to interact with Bcr-Abl, another approach is to use genetic analysis in Drosophila to identify functionally signi®cant interactions. The high level of conservation that exists between human and Drosophila Abl (Henkemeyer et al., 1988) , along with the recent identi®cation of mammalian homologs of ena (Gertler et al., 1996) and dab (Howell et al., 1997) , two components of the Drosophila Abl signalling pathway, lend support to the idea that Abl, and presumably Bcr-Abl, signal transduction pathways are highly conserved.
One way in which functional analogies between vertebrate proto-oncogenes and their counterparts in Drosophila have been demonstrated is to show that Drosophila homologs or chimeras of Drosophila and vertebrate oncogenes transform vertebrate cells in culture (Schejter and Shilo, 1985; Holland et al., 1990; Egan et al., 1993; Ramakrishna and Brown, 1993; Paulson et al., 1997) . We have taken the opposite approach to explore functional analogies between Drosophila abl and human bcr-abl using¯ies expressing human/¯y chimeric bcr-abl oncogenes. We found that neural expression of chimeric P210 and P185 BcrAbl can substitute for Drosophila Abl during axonogenesis and that increased levels of phosphorylation of the Drosophila Abl substrate, Ena, occur in¯ies expressing Bcr-Abl. We also describe dominant CNS defects associated with higher neural expression of BcrAbl and a dominant rough eye phenotype associated with Bcr-Abl expression in the eye imaginal disc. Our results suggest that Drosophila is a suitable model system to identify genetically Bcr-Abl interactions important for signal transduction and oncogenesis.
Results
We generated stable bcr-abl transgenic¯y lines for tissue speci®c expression of human/¯y chimeric Bcr-Abl proteins encoded by 5' human P210 and P185 bcr-abl sequences fused to 3'¯y abl sequence (Figure 1 ). Inclusion of Drosophila Abl carboxy-terminal amino acids is required for proper localization of Abl protein to the axon bundles . Expression of the transgenes: human/¯y chimeric P210 bcr-abl, (UAS-P210), human/¯y chimeric P185 bcr-abl (UAS-P185), Drosophila abl (UAS-Dabl), and kinase defective Drosophila abl (UAS-Dabl K417N ), was regulated by the binary GAL4-UAS system which utilizes the yeast GAL4 transcriptional activator to drive transgene expression (Brand and Perrimon, 1993) .
Adult survival of Abl mutant Drosophila expressing chimeric human/¯y Bcr-Abl proteins Flies that lack Abl either fail to eclose or are present as adults having roughened eyes, reduced longevity and reduced fecundity (Henkemeyer et al., 1987) . Previously it was shown that abl promoter-driven expression of chimeric human c-abl/¯y abl, chimeric viral gag-abl/¯y abl and both kinase active and kinase defective Drosophila abl transgenes rescued abl mutant animals to wild type, fertile adult¯ies . To ask whether expression of chimeric human/¯y UAS-P210 and UAS-P185 bcr-abl transgenes could provide Abl function in abl mutant¯ies, transgene expression was targeted to the CNS with the enhancer trap insertion, GAL4-31. The CNS was chosen because Drosophila Abl was previously shown to be expressed at high levels in the developing CNS and to play a role in axonogenesis (Gertler et al., 1989; Bennett and Homann, 1992) . Figure 1 Human/Drosophila chimeric P210 and P185 Bcr-Abl and Drosophila Abl proteins. The human/¯y chimeric P210 and P185 Bcr-Abl fusion proteins and Drosophila Abl are shown and the important protein domains and amino acids are highlighted. In the P210 chimeric construct bcr exons 1 ± 3, which code for 927 amino acids of Bcr, are fused to human abl exon 2. In the P185 construct only bcr exon 1, which codes for 426 amino acids of Bcr, is fused to human abl exon 2 sequences. Both chimeric constructs contain human abl exon 2 and the ®rst 204 codons of human abl exon 3 fused to Drosophila abl sequence at a conserved Ncol site located 47 codons into the Drosophila Abl protein tyrosine kinase domain . The resulting chimeric fusion protein consists of human Bcr sequences and either the human P210 or P185 Bcr-Abl fusion joint. The conserved Abl kinase SH2 and SH3 regulatory domains and conserved lysine (K) found in the ATP binding site (corresponds to Drosophila Abl K 417 ) located in the tyrosine kinase domain (TPK) are also derived from human abl sequence. The major tyrosine phosphorylation site (corresponds to Drosophila Abl Y 539 ) present in the Abl kinase domain and the less conserved Abl carboxyl terminal sequences important for localization are derived from Drosophila abl sequence. Numbers on the carboxy-terminal end of the protein structures refer to the number of amino acids in each protein , indicating that kinase-active Drosophila Abl protein is not required for rescue of abl mutant¯ies. This result concurs with a previous ®nding that abl promoter driven expression of a kinase-defective Drosophila abl transgene could provide rescue of abl mutant¯ies . Neural expression of UAS-P210 and UAS-P185 transgenes also resulted in variable rescue of fertility, ranging from 50 ± 100%. In contrast to abl promoter driven transgene expression, which also corrects the abl mutant rough eye phenotype, GAL4-31 driven expression of UAS-P210, UAS-P185, and UAS-Dabl in abl mutant¯ies failed to rescue the abl mutant rough eye phenotype. Presumably this dierence is due to dierences in the transgene expression pattern.
The dab gene was previously identi®ed in a genetic screen as a dominant enhancer of the abl mutant phenotype (Gertler et al., 1989) . Heterozygous deletion of dab in the absence of functional Abl causes a shift in lethality from pupal to embryonic stages and uncovers a requirement for Abl tyrosine kinase function in axonogenesis (Gertler et al., 1989; Henkemeyer et al., 1990) . Thus, whereas catalytically inactive Abl will completely rescue abl mutant¯ies, catalytically active Abl kinase is required to rescue abl mutant¯ies either hemizygous for dab by deletion or heterozygous for the dab m2 allele. A more rigorous test of P210 and P185 Bcr-Abl kinase function was to see whether neural expression of P210 and P185 Bcr-Abl could substitute for Drosophila Abl kinase in abl mutant¯ies heterozygous for dab m2 . Neural expression of UAS-P185 or UAS-DAbl rescued abl dab mutant animals to fertile adults having roughened eyes, although at lower levels compared to their rescue of abl mutant animals (Table 1 ). In this genetic background there were no viable abl dab mutant adults, and the number of¯ies rescued by expression of kinase-defective UASDabl K417N was greatly reduced compared to its near 100% rescue of abl mutant¯ies. Neural expression of UAS-P210 in abl dab mutant animals showed decreased levels of rescue compared to that seen with expression of UAS-P185 or UAS-Dabl, and its level of rescue was comparable to that seen with kinasedefective UAS-Dabl K417N . These rescue studies showed that neural expression of either P210 or P185 Bcr-Abl substituted for neural expression of¯y Abl in abl mutant¯ies. In a more stringent genetic background requiring functional Abl kinase activity, expression of Drosophila Abl and P185 Bcr-Abl produced more rescue than P210 Bcr-Abl or kinase defective Drosophila Abl.
Higher expression of Bcr-Abl in the CNS causes CNS defects Drosophila Abl is normally localized in the fasciculating axons of the CNS during late embryogenesis (Gertler et al., 1989) . In the course of testing various transgenic lines for rescue, we observed that neural expression of one particular P210 insertion, UAS-P210
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, resulted in few viable progeny when the crosses were kept at 258C. This eect was also observed in a wildtype abl background (data not shown) and . In all panels, an arrowhead points to the longitudinal axons, a horizontal arrow points to commisural axons and a diagonal arrow at the bottom points to axons exiting the CNS. Bar, 50 mM therefore is dominant lethal. GAL4 activity is temperature sensitive (Brand and Perrimon, 1993) , and because viable adults neurally expressing protein from the UAS-P210 31 insertion were only recovered from crosses kept at 188C, we hypothesized that an increased level of transgene expression with this insertion accounted for lethality at 258C. We therefore examined the CNS of crosses incubated at 298C to generate maximal levels of UAS-P210, UAS-P185, or UAS-Dabl transgene expression using mAb BP102 to visualize the nerve cord and learn whether CNS defects were associated with increased levels of Bcr-Abl transgene expression (Figure 2 ).
Embryos expressing increased levels of Drosophila Abl in the CNS showed no visible CNS defects ( Figure  2b ), and their nerve cords appear similar to those dissected from wild type embryos (Figure 2a ). In contrast, neural expression of P185 or P210 Bcr-Abl produced defects in the CNS in an abl wild type background. Embryos expressing elevated levels of P210 Bcr-Abl from the insertion UAS-P210 31 have the most severe CNS defects ( Figure 2d ). The longitudinal (arrowhead) and commisural axons (horizontal arrows) are less tightly bundled and increased numbers of axons exit the CNS from the longitudinal tracts (diagonal arrow). Similar, although slightly less severe CNS defects, were also observed in embryos expressing elevated levels of P185 Bcr-Abl ( Figure 2c ). These results indicated that neurally expressed Bcr-Abl generated dominant CNS defects that correlate with lethality.
Expression of Bcr-Abl and overexpression of Drosophila Abl in the eye imaginal disc causes eye defects
The Drosophila compound eye is comprised of an orderly array of 700 ± 800 identical units called ommatidia (see Figure 3a for scanning electron microscopy (SEM) picture of a wild type eye; asterisk in Figure 3e marks the center of a single wild type ommatidial facet). Each ommatidium contains eight photoreceptor neurons, retinal cells R1-R8, and additional accessory cells. Ommatidial assembly is initiated in a monolayer epithelial eye imaginal disc during the third instar larval stage (eye development reviewed by Ready et al., 1976; Lawrence and Green, 1979; Tomlinson, 1988) . Abl protein is present in the dierentiating eye disc and abl mutant¯ies have a rough eye phenotype characterized by reduced numbers of irregularly shaped facets and missing or supernumerary bristles (Henkemeyer et al., 1987; Bennett and Homann, 1992) . Since Drosophila Abl plays a role in normal eye development, we asked whether ectopic expression of Bcr-Abl and Drosophila Abl in the eye imaginal disc aected eye development.
Transgene expression was targeted with the enhancer trap insertion line sev-GAL4 that activates expression in the developing eye imaginal disc (Basler et al., 1990) . Sev-GAL4 driven expression of UAS-Dabl produced viable, fertile adults having a mild roughened eye phenotype that was clearly visible under the dissecting microscope. SEM revealed ommatidial facets that lacked the normal wild type hexagonal shape and were often fused (compare wild type ommatidial facet (marked with an asterisk in Figure 3e ) to fused ommatidia (marked with arrow in Figure 3f) ).
Additionally, misplaced mechanosensory bristles were often seen (arrowhead in Figure 3f ). Sev-GAL4 driven expression of a transgene encoding a kinase defective UAS-Dabl K417N produced no detectable eye phenotype, indicating that the UAS-Dabl induced rough eye phenotype was Abl kinase dependent (data not shown).
Expression of P210 or P185 Bcr-Abl in the eye imaginal disc resulted in viable, fertile adults with a severe rough eye phenotype. SEM of Bcr-Abl expressing eyes from adult¯ies revealed small, barshaped eyes with markedly decreased numbers of ommatidial facets ( Figure 3c and d and Figure 3g and h). The ommatidial facets lacked the normal wild type hexagonal shape and varied in size. At higher magni®cations, multiple misplaced mechanosensory bristles (arrowheads in Figure 3g and h) as well as lens defects (manifest as holes in the lens, arrow in Figure 3g and h) were observed.
The severity of the eye phenotype correlated with the level of Bcr-Abl transgene expressed (Figure 4a and b) . Increased levels of P185 Bcr-Abl were observed in pupae expressing protein from two copies of UAS-P185 bcr-abl (Figure 4b ). In conclusion, these results indicate that increased levels of Bcr-Abl expression correlate with more severe phenotypes. In contrast, overexpression of Drosophila Abl (Figure 4b , lane 2) generated only a mild rough eye phenotype (Figure 3b ).
To determine whether the rough eye phenotype observed in Bcr-Abl and Drosophila Abl expressing eyes re¯ected an overall disruption of photoreceptor development, sections of adult eyes were examined by light microscopy. Section of wild type eyes had the characteristic trapezoidal cluster of retinal cells present in each ommatidium (Figure 5a , arrowhead points to a single ommatidium containing seven photoreceptor cells). In this plane of section, photoreceptor cells R1-R7 were visible whereas R8 was not seen since it lies below R7 in the center of the ommatidium (Ready, 1989) . Each ommatidium was surrounded by a ring of secondary and tertiary pigment cells that form a continuous honeycomb lattice. Sections of Drosophila Abl expressing eyes revealed ommatidia that were irregular in size and shape and showed an altered trapezoid orientation of photoreceptor cells ( Figure  5b ). The linearity of the ommatidial arrangement was disrupted, and numerous gaps appeared between ommatidia (arrow in Figure 5b ). Most ommatidia contained the correct number of photoreceptor cells, but occasionally ommatidia were observed to have an aberrant number of photoreceptor cells (arrowheads in Figure 5b point to one ommatidium having six and another having eight photoreceptor cells). Eye sections from sev-GAL4 driven UAS-P185 (Figure 5c ) and UAS-P210 (Figure 5d ) expression exhibited severe disruptions in morphology. Bcr-Abl expressing eyes had fewer ommatidia and those present appeared to be missing one or more retinal cells and/or to have elongated or fused rhabdomeres or retinal cells (arrowheads in Figure 5c and d). The secondary and tertiary pigment cells were also disorganized (arrow in Figure 5d points to disarrayed pigment cells) and the continuous honeycomb lattice these cells normally form over the eye was absent. In general, we found that sev-GAL4 driven expression of UAS-P210 resulted in more severe eye defects than did expression of UAS-P185.
The abnormal ommatidia observed in sev-GAL4 driven Bcr-Abl expression could be due to a failure of cell proliferation or to alterations in cell fate Figure 3 Eects of sev-GAL4 driven expression of Drosophila Abl, P185 Bcr-Abl and P210 Bcr-Abl on adult eye morphology. Scanning EM of compound eyes from¯ies with the following genotypes: (a) and (e) +; sev-GAL4, (b) and (f) ; sev-GAL4, (c) and (g) UAS-P185 17 ; sev-GAL4, (d) and (h) UAS-P210
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; sev-GAL4. In (e) an asterisk marks the center of one ommatidial facet. An arrow points to fused ommatidia in (f) and to lens defects in (g), and (h). Arrowheads in (f), (g) and (h) point to multiple misplaced mechanosensory bristles. Bar, 150 mM in a ± d; Bar, 15 mM in e ± h ; sev-GAL4, (6) UAS-P210
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; sev-GAL4. Lane 7 contains 10 ng of puri®ed recombinant, His-tagged Drosophila Abl protein . Cross-reactive lower bands that appear in all lanes demonstrate that relatively equal amounts of protein are present in lanes 3 and 4, which compare levels of P185 protein expressed from 1 versus 2 copies of P185 Bcr-Abl, and in lanes 5 and 6, which compare levels of P210 protein expression from the UAS-210 11 insertion versus the UAS-210 31 insertion. A major Abl proteolytic frament is present in both the puri®ed recombinant Drosophila Abl prep (lane 7, marked with an asterisk) and in the lysate prepared from pupae overexpressing Drosophila Abl (lane 2, asterisk). A slightly larger breakdown product appears in lysates from pupae expressing increased levels of P185 Bcr-Abl (lane 4, asterisk) or increased levels of P210 Bcr-Abl (lane 6, asterisk) determination. Alternatively, Bcr-Abl expression in the developing eye disc might disrupt the differentiation of determined cells and produce degeneration. To distinguish between these possibilities we stained eye imaginal discs with anti-ELAV, an antibody speci®c for neuronal cells (Robinow and White, 1991) . Normally, nuclei of developing photoreceptor cells that are committed to a neuronal cell fate express the ELAV protein in a sequential manner that parallels their recruitment into the developing ommatidial cluster (Tomlinson, 1988) . Sev-GAL4 driven UAS-Dabl expression (Figure 6b ) did not appear to grossly disrupt ommatidial cluster formation inasmuch as the anti-ELAV staining pattern resembled that of wild type eye discs (Figure 6a ). Patterning defects were observed in the eye imaginal discs with sev-GAL4 directed expression of UAS-P210 and UAS-P185 (Figure 6c ± e) . ELAV-positive, three-cell clusters consisting of R8, R2, and R5 appeared to form normally near the morphogenetic furrow. However, recruitment of additional ELAV-positive photoreceptor cells to form ®ve-cell ommatidial preclusters and eight-cell mature ommatidial clusters in the central and more posterior regions of these eye discs was aberrant. Quite often, we observed anti-ELAV staining three-or four-cell clusters (arrowheads in Figure 6c and d) or occasionally a single cell in the posterior regions of the eye disc where normally mature eight-cell clusters exist. Gaps between ommatidial clusters and mis-aligned clusters were also observed (compare ommatidial clusters in Figure 6c and d to linear arrangements of tightly arrayed ELAV-positive cell clusters in Figure 6a and b). Defects in ommatidial cluster formation were most apparent in eye discs with sev-GAL directed expression of UAS-P210 31 ( Figure 6e ) and correlate with the severe adult eye phenotype observed by SEM (Figure 4a, panel d) . In this case, ommatidial clusters comprised of only two or three ELAVpositive neuronal cells were observed in the posterior region of the eye disc (arrow in Figure 6e points to a three-cell cluster located in the posterior region of the eye disc).
Expression of Bcr-Abl in¯ies produces increased phosphorylation of the Drosophila abl substrate, Ena
Ena was previously identi®ed in a genetic screen for dominant second site mutations that suppress the lethality of abl . Drosophila Ena functions as a phosphotyrosine substrate for human and Drosophila Abl kinase when co-expressed in cells (Gertler et al., 1995) . The observation that abl mutant ies show a two-to threefold decrease in Ena phosphotyrosine content suggests that Ena also functions as an Abl phosphotyrosine substrate in vivo (Gertler et al., 1995) . We looked at whether endogenous Ena tyrosine phosphorylation is increased in animals expressing Bcr-Abl under the control of the ; sev-GAL4, (e) UAS-P210
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; sev-GAL4. The discs are stained with anti-ELAV to detect photoreceptor cells committed to a neuronal cell fate within the developing ommatidium. All panels are taken from the posterior region of the eye imaginal discs. Arrowheads in (c), (d) and (e) point to developing ommatidial clusters containing reduced number of ELAV-positive cells. Also note the large gaps between ommatidial clusters in (c ± e) compared to the tightly arrayed ommatidial clusters in (a) and (b). Bar, 5 mM scabrous-GAL4 driver which generates expression in the CNS and peripheral nervous system (PNS). Although all lines produced equivalent amounts of Ena (Figure 7a and b, bottom panels), increased levels of Ena tyrosine phosphorylation were observed in UAS-P210, UAS-P185, and UAS-Dabl expressing¯ies (Figure 7a and b, top panel, lanes marked with +) compared to transgenic lines that lacked the GAL4 activator (Figure 7a and b top panels, lanes marked  with 7) . Furthermore, the level of Ena phosphotyrosine was markedly higher in the Bcr-Abl expressing embryos compared to the Drosophila Abl expressing embryos (Figure 7a , top panel) even though equivalent amounts of Ena were immunoprecipitated (Figure 7a , bottom panel). This result suggests that both P210 and P185 Bcr-Abl have higher in vivo kinase activity for Ena than does Drosophila Abl.
Discussion
We generated transgenic Drosophila expressing human/ y chimeric Bcr-Abl oncoproteins for the purpose of developing a genetic model system that can be used to study the Bcr-Abl signal transduction pathway. As a ®rst step toward characterizing this Drosophila model system we asked whether human/¯y chimeric P210 and P185 Bcr-Abl could functionally substitute for Drosophila Abl in abl mutant¯ies. We found that neural expression of human/¯y chimeric P210 or P185 Bcr-Abl could substitute for Drosophila Abl protein to signal downstream targets important for axonogenesis. One interesting dierence between chimeric P210 and P185 Bcr-Abl was in their ability to rescue abl dab mutant¯ies. Neurally expressed P185 Bcr-Abl, but not P210 Bcr-Abl, functionally substituted for Drosophila Abl kinase in the more stringent abl dab genetic background that requires Abl kinase function indicating that chimeric P185 Bcr-Abl phosphorylates one or more critical Abl downstream targets required for axonogenesis. P185 Bcr-Abl, which is associated with a more aggressive form of leukemia, is reported to have at least ®ve-fold higher levels of kinase activity compared to P210 Bcr-Abl and this activity might explain the dierences in rescue (Lugo et al., 1990 ). An alternative explanation is that expression of additional Bcr sequences present in the larger P210 Bcr-Abl protein produce lethality in this sensitized abl dab genetic background. Our ®nding of dominant phenotypes associated with higher levels of Bcr-Abl expression in the CNS or eye imaginal disc and our general observation of more severe phenotypes associated with P210 expression support the idea that Bcr-Abl and in particular P210 Bcr-Abl expression is disruptive to normal dierentiation. The disruptive eects of Bcr-Abl expression may compromise the ability of the chimeric proteins to rescue abl mutant ies. (7). The blots show that Ena (arrow) contains more phosphotyrosine in embryos expressing the target transgenes (+) compared to the non-expressing embryos (7). Embryos expressing P210 and P185 Bcr-Abl had increased phosphotyrosine content of Ena compared to embryos expressing Drosophila Abl. The same blots reprobed with anti-Ena antibody show comparable levels of Ena were immunoprecipitated from samples or were present in the total lysates. Molecular weight standards (in daltons): myosin (207 000), B-galactosidase (139 000), bovine serum albumin (84 000), carbonic anhydrase (41 700) and soybean trypsin inhibitor (32 000)
Higher levels of P210 and P185 Bcr-Abl neural expression produced CNS defects reminiscent of that which is seen in ena mutant animals in that longitudinal and commisural axons appeared less tightly bundled and increased numbers of axons exited the CNS from the longitudinal tracts (Gertler et al., 1995) . The results with Bcr-Abl are interesting in light of the fact that Drosophila Abl tyrosine kinase and Ena are proposed to play a role in regulating cytoskeletal changes during axonogenesis (Gertler et al., 1995) . Of related interest is the ®nding that in mammalian systems, Bcr-Abl is also observed to alter cytoskeletal function and cell adhesion. bcr-abl transformed cells have altered actin cytoskeletal structures, demonstrate abnormal cell motility on ®bronectin-coated surfaces, and contain a number of of focal adhesion associated proteins that are tyrosine phosphorylated by Bcr-Abl (Salgia et al., 1995b (Salgia et al., , 1997 .
Expression of human/¯y chimeric Bcr-Abl in the developing eye imaginal disc produced a dominant rough eye phenotype. Anti-ELAV staining revealed defects in recruitment of photoreceptor cells to the developing ommatidial clusters suggesting that early patterning defects are the cause of the adult rough eye phenotype. In contrast, sev-GAL4 directed expression of Drosophila Abl produced a milder rough eye phenotype and normal ommatidial cluster formation in the eye imaginal disc. sev-GAL4 targets high levels of transgene expression to R3, R4, R7 and to the cone cells, and lower levels of expression to R1 and R6 (Basler et al., 1990) . The initial formation of ELAVpositive three-cell clusters comprised of R8, R2 and R5 cells appears normal in all sev-GAL4 targeted Bcr-Abl lines, including line UAS-P210 31 , presumably because these cells are not expressing Bcr-Abl. The appearance of defects coincided with the recruitment of those cells expressing sev-GAL4 targeted Bcr-Abl, namely R1, R3, R4, R6 and R7, whereas the lens defects probably re¯ect the detrimental eects of Bcr-Abl expression in the lens-secreting cone cells.
Interestingly, abl mutant adults also exhibit a rough eye phenotype associated with defects in the photoreceptor cell clusters early in ommatidial development (Bennett and Homann, 1992) . Defects in adhesion have been proposed to explain the general lack of hexagonal arrangement of ommatidia observed in sections through abl mutant eyes (Bennett and Homann, 1992) . We speculate that Bcr-Abl expression in the developing eye disc may also alter intercellular adhesion resulting in disruption of cell dierentiation.
There are several potential explanations for the dominant phenotypes produced by Bcr-Abl expression. One explanation is that the dominant phenotypes are a direct result of increased tyrosine kinase activity. The tyrosine kinase activity of Bcr-Abl is known to be an essential determinant of its transforming potency (Lugo et al., 1990; Oda et al., 1995) . Our observation that ectopic expression of Drosophila Abl generates a mild rough eye phenotype that is absent in lines expressing kinase defective Drosophila Abl shows that overexpression of Drosophila Abl kinase activity can produce mild rough eye phenotypes. We observed that animals expressing P210 or P185 Bcr-Abl had increased levels of Ena tyrosine phosphorylation compared to animals expressing Drosophila Abl. This ®nding may be signi®cant for two reasons. First, Ena seems well suited to modulate cytoskeletal changes with structural motifs that include a highly conserved amino terminal zyxin binding domain, a central proline rich region that can bind SH3 domains and pro®lin, and a carboxy-terminal domain that may mediate multimerization and cellular localization (Gertler et al., 1996; Ahern-Djamali et al., 1998) . Second, Abl-phosphorylated Ena shows reduced binding to the SH3 domains of both Abl and Src in vitro which raises the possibility that phosphorylation may modulate Ena's interactions with other proteins . One interpretation of the Bcr-Abl induced CNS defects is that hyperphosphorylation of Ena by BcrAbl results in disruption of Ena interactions with other cytoskeletal proteins important in axonal cytoarchitecture. The de®nitive experiment to address this question will require the generation of transgenic¯ies expressing kinase defective Bcr-Abl and eort is currently underway to generate these lines.
A second possible explanation for the dominant phenotype caused by Bcr-Abl expression is that BcrAbl sequesters downstream signal transducing molecules and eectively competes with other signal transduction pathways important for CNS and eye development. One possibility is that SH3 and SH2 domains present in Bcr-Abl compete with Drosophila Abl or possibly other, as yet unidenti®ed, signal transducing proteins for binding of Ena and Dab. Ena functions as a substrate for both Drosophila Abl and Bcr-Abl kinase and was previously demonstrated to bind Abl and Src SH3 domains . Dab interacts genetically with Drosophila abl (Gertler et al., 1989) and tyrosine phosphorylated mouse Dab (mDab1) is reported to associate with SH2 domains of Src, Fyn and Abl (Howell et al., 1997) . To test the hypothesis that Bcr-Abl competes with endogenous Drosophila Abl for limited quantities of Ena or Dab, we have surveyed the results of sev-GAL4 driven BcrAbl expression in animals heterozygous for the ena null allele (ena GC1 ) (Gertler et al., 1995) and in animals heterozygous for the Df(3L)std11 chromosome which uncovers abl and dab (Gertler et al., 1989) ; the Bcr-Abl rough eye phenotype was unchanged (data not shown). These results argue against a simple model where BcrAbl sequesters Ena and/or Dab away from Drosophila Abl to reduce Abl signalling during eye development but do not rule out the possibility that Bcr-Abl SH3 and SH2 domains compete for binding of other important signal transducers.
A third explanation is that expression of functional domains present in Bcr cause the dominant phenotypes. A potentially important binding site present in both P210 and P185 Bcr-Abl is tyrosine 177 which upon phosphorylation binds the mammalian SH3/SH2 adaptor protein, Grb2, to activate the Ras pathway during transformation (Pendergast et al., 1993; Puil et al., 1994) . One scenario is that overexpression of Bcr-Abl in the developing eye competes with the Sevenless tyrosine kinase signal transduction pathway for the Drosophila Grb2 homolog, Drk and thus interferes with the dierentiation of photoreceptor cells (Olivier et al., 1993; Simon et al., 1993) . Experiments are underway to test this hypothesis by looking at sev-GAL4 driven BcrAbl expression in animals heterozygous for deletion of drk and other components in the Sevenless signalling pathway. The fact that extra R7 cells were not observed when Bcr-Abl was overexpressed in the eye imaginal disc argues against the idea that the observed rough eye phenotype is due to Bcr-Abl activation of Ras in this model system. Another Bcr domain present in both P210 and P185 is an N-terminal coiled-coil domain which has been proposed to promote homo-oligomerization and activation of Abl tyrosine kinase activity (McWhirter et al., 1993) as well as interaction of Bcr-Abl with SH2-containing downstream signalling molecules (Tauchi et al., 1997) . A serine/threonine kinase domain represents a third functional domain contributed by Bcr ®rst exon sequences (Maru and Witte, 1991) . Whether these BcrAbl domains play a role in the generation of the dominant CNS and eye phenotypes is not known and can be probed by mutation of residues critical for Drk/ Grb 2 binding, homo-oligomerization and enzymatic activity.
Finally, a tandem Dbl-homology and pleckstrin homology (PH) domain are two additional function domains present in P210 but not P185 Bcr-Abl. Dblhomology domains encode guanine nucleotide exchange factor activity that can activate Rho-type small GTP binding proteins . PH domains, which are often found in tandem with Dbl homology domains, are abundant in proteins involved in signal transduction and may target Dbl to speci®c cytoskeletal locations where it may activate Rho-type small GTP bindings proteins and modulate the cytoskeleton McWhirter and Wang, 1997) . At this time we do not know whether these domains play a role in the generation of Bcr-Abl induced dominant phenotypes but it is possible they contribute to the phenotypic dierences observed in P210 and P185 Bcr-Abl expression.
The discovery of a dominant eye phenotype associated with Bcr-Abl expression in the eye imaginal disc provides a quantitative in vivo assay for Bcr-Abl function. Our model can be used to identify genetically other components in Bcr-Abl signal transduction pathways and to test therapeutic stratagies that target Bcr-Abl or other components in the pathways. Further characterization of the eye and CNS phenotypes associated with Bcr-Abl expression in Drosophila should help elucidate the mechanism of action of Bcr-Abl and its role in transformation. Finally, our approach may be applicable for the study of other conserved oncogenic signalling pathways.
Materials and methods

Construction of chimeric bcr-abl cDNAs
As a ®rst step toward generating bcr-abl chimeric cDNA sequences, we constructed chimeric human/¯y abl in pBluescript, pBS abl hu/¯y . A 949 nucleotide NotI-NcoI fragment of human abl from cDNA P18 (Fainstein et al., 1989) , was joined to Drosophila abl cDNA at a conserved NcoI site located 47 codons into the Drosophila Abl protein tyrosine kinase domain as previously described . Next a 3 kb EagI ± KpnI fragment of P210 bcr-abl and 1.6 kb EagI ± KpnI fragment of P185 bcrabl from plasmid (-447 p210 pMV6tkNeo) and plasmid (-447 p185 pMV6tkNeo) respectively (from S Clark, University of Wisconsin) (McLaughlin et al., 1989) , was ligated to a 5.3 kb KpnI ± NotI abl hu/¯y fragment from pBS abl hu/¯y . The P210 and P185 chimeric cDNA sequences contain 10 nucleotides of 5' untranslated sequence, either the P210 or P185 bcr-abl fusion joints, and human abl fused to Drosophila abl at a conserved NcoI site (see Figure  1) . The chimeric bcr-abl cDNAs were excised by NotI digestion and subcloned into the pUAST P-element vector for injection into Drosophila embryos.
Generation of bcr-abl transgenic¯ies
Chimeric bcr-abl constructs were subcloned into the Pelement expression vector, pUAST, downstream of a promoter comprised of ®ve tandem GAL4 binding sites referred to as UAS (Upstream Activation Sequence) and transformed into¯ies (Brand and Perrimon, 1993) . Transgenic lines were generated by injecting CsCl banded DNA at a concentration of 400 mg/ml into embryos (w; +/ +; D2 ± 3) using standard protocols (Santamaria, 1986; Spradling, 1986; Robertson et al., 1988) . Within the text, a superscript denotes a speci®c transgene insertion. To generate progeny expressing the target gene in a tissuespeci®c pattern,¯ies carrying the target transgenes were crossed to¯ies expressing the yeast transcriptional activator, GAL4, in the CNS (GAL4-31), in the eye imaginal disc (sev-GAL4) and in the CNS and PNS (scabrous-GAL4).
Expression of Bcr-Abl fusion proteins in transgenic¯ies
Abl mutant¯ies were generated using the abl 1 point mutation and chromosomes containing either a deletion of the abl gene, (Df(3L)stj7 Ki roe pP), (abbreviated abl 7 in tables) (Henkemeyer et al., 1987) or an abl deletion in combination with the dab m2 mutant allele, (dab m2 Df(3L)stj7 Ki roe pP) (Gertler et al., 1989) . The abl 1 mutant allele encodes a truncated protein unable to properly localize to axons during embryonic CNS development and when heterozygous with an abl deletion produces a mix of pupal lethality and mutant adults (Henkemeyer et al., 1987) . The enhancer trap insertion GAL4-31, which activates transcription in the CNS, was recombined onto the Df(3L)stj7 Ki roe pP and dab m2 Df(3L)stj7 Ki roe pP mutant third chromosomes. All crosses were incubated at 258C unless otherwise indicated. The TM6,B balancer on the third chromosome carries the dominant Tubby (Tb) marker that generates¯ies having short stubby bodies so¯ies carrying two abl mutant chromosomes were easily identi®ed as Tb + . Animals carrying the abl 7 deletion and GAL4-31 driver can be identi®ed by the presence of the dominant bristle marker, Kinked (Ki).
To test rescue,¯ies carrying one copy of the target transgenes on the second chromosome (UAS-P210/CyO, UAS-P185/CyO, UAS-Dabl/CyO, UAS-Dabl K417N /CyO) or no target transgene (CyO/Gla) and heterozygous for the abl 1 point mutation on the third chromosome (abl 1 /Tb) were mated to animals of the genotypes, CyO/Sp; Df(3L)stj7 Ki roe pP, P[GAL4-31]/Tb or CyO/Sp; dab m2 Df(3L)stj7 Ki roe pP, P[GAL4-31]/Tb¯ies respectively. The percentage of adult survival was calculated by dividing the number of Tb +¯i es recovered by the expected number of Tb +¯i es. The expected number of Tb +¯i es was assumed to be equal to one-half the number of Tb siblings scored. Numbers shown in Table 1 are the average percent viable adults obtained from duplicate or triplicate crosses of three dierent transgene insertions on the second chromosome for UAS-Dabl, UAS-P185 and UAS-P210 and two dierent transgene insertions on the second chromosome for UAS-Dabl K417N . At least 1000¯ies were scored for each transgene category.
Immunohistochemistry
To examine the CNS, embryos expressing the target transgenes were generated from crosses of UAS-P210/ CyO elav-lacZ ; +/+, UAS-P185/CyO elav-lacZ ; +/+ and UASDabl/CyO elav-lacZ ; +/+ to +/+; GAL4-31/TM2 ftz-lacZ¯i es.
Crosses were kept at 298C to generate high levels of protein expression. Embryos staged between 10 and 18 h of development were ®xed and stained with a 1 : 10 dilution of mouse mAb BP102 [Developmental Studies Hybridoma Bank (DSHB)] to detect the CNS axons as previously described (Hill et al., 1995) . Mouse monoclonal anti-b-gal antibody (Promega, Madison, WI) was used to detect the lacZ enhancer trap-containing balancer chromosome and distinguish UAS-transgene expressing embryos from their non-expressing siblings. The secondary antibody, biotinylated goat anti-mouse IgG, and streptavidin-horseradish peroxidase conjugate (Boehringer Mannheim, Indianapolis, IN) were used at a ®nal dilution of 1 : 300. Nerve cords were dissected from stained embryos and mounted in 90% glycerol.
To examine phenotypes in the eye imaginal discs, embryos expressing the target transgenes were generated from matings of¯ies bearing wild type second chromosomes and homozygous for the sev-GAL4 enhancer trap insertion on the third chromosome, +/+; sev-GAL4/sev-GAL4, to¯ies that were homozygous or heterozygous for transgene insertions on the second chromosome with the following genotypes: UAS-P210 ; +/+ and UAS-Dabl/UAS-Dabl; +/+. As a control, w; +; +¯ies were mated to the sev-GAL4 enhancer trap line to generate larvae heterozyous for sev-GAL4 but lacking a target transgene. Crosses were kept at 258C. Disc complexes from third instar crawling larvae were dissected in phosphate buered saline (PBS), ®xed 30 min in (100 mM Pipes, pH 7.0, 2 mM MgSO 4 , 1 mM EGTA, 1% NP40, 2%. formaldehyde), washed in PBS with 0.3% Triton X-100 (PBST) and then blocked in 5% BSA/PBST for several hours. Disc complexes were stained overnight at 48C with rat anti-ELAV (7E8A10) (DSHB) diluted 1 : 1000 in 1% BSA/PBST. To detect bound antibody, disc complexes were incubated ®rst with biotinylated anti-rat mAb (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) diluted 1 : 200 in 1% BSA/PBST followed by a 60 min incubation with a 1 : 200 dilution of streptavidin-HRP (Boehringer Mannheim, Indianapolis, IN), and then incubated in 200 ml of developing solution (0.3 mg/ml DAB, 0.064% NiCl 2 , 0.01% H 2 0 2 ) until color appeared. Discs were stored in 30% mounting solution (30% glycerol, 50 mM Tris, pH 8.8, 150 mM NaCl, 0.02% NaN 3 ).
Scanning electron microscopy
External eye morphology of various transgenic¯y lines was visualized by SEM. Eyes for SEM were isolated from Drosophila expressing protein from one copy of the P185 bcr-abl, P210 bcr-abl or Drosophila abl transgenes (UAS-P185 17 ; sev-GAL4, UAS-P210 11 ; sev-GAL4, UAS-P210 31 ; sev-GAL4, UAS-Dabl 22 ; sev-GAL4). To generate Drosophila with two copies of P185, UAS-P185 17 and UAS-P185 6 insertions were recombined onto the same chromosome and eyes for SEM were isolated from UAS-P185 6 , UAS-P185 17 ; sev-GAL4 adults. Eyes were also isolated from Drosophila heterozygous for sev-GAL4 but lacking a target transgene (+; sev-GAL4). Crosses to generate Drosophila of the indicated genotypes were maintained at 258C except for crosses to generate UAS-P210 31 ; sev-GAL4 which had to be maintained at 188C in order to obtain viable adults. Anesthesized¯ies were decapitated under a dissecting scope and heads were placed in ®xative (2.5% glutaraldehyde in 0.05 M cacodylate buer (pH 7.2) containing 0.1 M sucrose) (Juang and Carlson, 1994) . Tissues were washed in three changes of buer, 0.05 M cacodylate buer (pH 7.2) containing 0.35 M sucrose and then subjected to post®xation in 1% OsO 4 in 0.05 M cacodylate buer (pH 7.2) containing 0.35 M sucrose for 60 min at room temperature. Tissue was then passed through an ascending ethanol series for dehydration, critically point dried, mounted and sputter coated with a ®ne layer of gold.
Light microscopy of eye thick sections
Eyes for section preparations were isolated from Drosophila with the following genotypes: UAS-P210 11 ; sev-GAL4, UAS-P185 17 ; sev-GAL4, UAS-Dabl 22 ; sev-GAL4 and CyO; sev-GAL4. Crosses were maintained at 258C. Adult Drosophila heads were ®xed and embedded in Eponate resin as described (Brown et al., 1991) . Sections of 0.5 mm were mounted in Polymount medium (Polyscience Inc., Warrington, PA) and viewed under phasecontrast optics on a Zeiss Axiophot microscope.
Immunoprecipitation and Western blot analysis
To compare Bcr-Abl protein expression levels in dierent transgenic lines pupal lysates were Western blotted with Protein A-puri®ed antibody raised against B-galactosidase-Abl bacterial fusion protein, pURABLkin (Henkemeyer et al., 1988; Bennett and Homann, 1992) . Pupae of the following genotypes were collected from crosses kept at 258C: (1) +; sev-GAL4, (2) UAS-Dabl 22 ; sev-GAL4, (3) UAS-P185 17 ; sev-GAL4, (4) UAS-P185 6 , UAS-P185 17 ; sev-GAL4, (5) UAS-P210 11 ; sev-GAL4, and (6) UAS-P210 31 ; sev-GAL4. Six pupae were homogenized in 60 ml of boiling 26reducing SDS sample-buer and incubated 10 min at 1008C. Lysates were then centrifuged (13 000 g) 5 min and supernatants were transferred to new tubes. Approximately 1 pupal equivalent (5 ml) of each lysate were run on a 8.0% SDS-polyacrylamide mini-gel. Proteins were transferred to Immobilon-P PVDF membrane (Millipore, Bedford MA). Transfer was carried out at 0.1 A in the cold room (48C) overnight in transfer buer (25 mM Tris, 192 mM glycine, 10% MeOH) and membrane was blocked for 1 h in 5% BSA/TBST. For detection of Bcr-Abl and Drosophila Abl proteins membrane was incubated with 2.2 mg/ml of rabbit antiablkin in 1% BSA/TBST for 1 h, washed with TBST then incubated with a 1 : 5000 dilution of peroxidase-conjugated goat anti-rabbit (ICN, Costa Mesa, CA) in 1% BSA/ TBST washed and developed using Western blot chemiluminescence reagent (NEN, Boston, MA).
For immunoprecipitation and Western blot analysis of Ena phosphotyrosine,¯ies homozygous for the target transgenes were crossed to the homozygous GAL4 activator line, scabrous-GAL4 to generate a homogeneous population of embryos expressing high levels of the transgene in the CNS and PNS. Crosses were maintained at 258C. As a control the UAS-P210 11 , UAS-P185 17 and UAS-Dabl 22 transgenic¯ies were crossed to w; +; +¯ies to generate progeny that carry the target transgene but lack the GAL4 activator to turn on transcription. For immunoprecipitation from embryos, *0.05 ml of embryos were homogenized in 0.25 ml of immunoprecipitation (IP) buer (1.0% NP-40, 0.5% DOC, 0.1% SDS, 150 mM NaCl, 50 mM Tris (pH 8.0), 5 mM EDTA) containing 1 mM Na 3 VO 4 , 1 mM Pefabloc (Boehringer Mannheim, Indianapolis, IN), 1 mg/ml each of aprotinin, leupeptin and pepstatin). Samples were lysed on ice for 30 min and then diluted to 1 ml ®nal volume with NP40 dilution buer (1% NP40, 150 mM NaCl, 50 mM Tris (pH 8.0)) and same protease inhibitors as above. The insoluble debris was pelleted for 20 min at 48C. Lysates were precleared by incubating with preimmune IgG and Protein A agarose (Pierce, Rockford, IL) at 48C for 1 h. Precleared lysates were incubated with 2.5 mg of rabbit polyclonal anti-Ena for 4 h at 48C. Immune complexes were collected with Protein A, washed once with IP buer followed by four washes with 10 mM Tris (pH 7.4), 150 mM NaCl, 0.05% Tween 20 (TBST) and boiled in reducing SDSsample buer. Samples were run on a 8.0% SDSpolyacrylamide gel and transferred to Immobilon-P PVDF membrane as described above. For detection of phosphotyrosine, membranes were incubated with mAb 4G10 (Upstate Biotechnology Inc., Lake Placid, NY) at 1 mg/ml in 1% BSA/ TBST, washed with TBST then incubated with peroxidaseconjugated goat anti-mouse (Jackson Labs) in 1% BSA/ TBST, washed and developed as described. To reprobe blots with anti-Ena, ®lters were stripped as recommended by the manufacturer and reprobed with 0.5 mg/ml rabbit anti-Ena followed by peroxidase-conjugated anti-rabbit in 1% BSA/ TBST and developed.
